EKF — EKF Diagnostics Holdings Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapContrarian

Annual income statement for EKF Diagnostics Holdings, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	65.3	81.8	66.6	52.6	50.2
Cost of Revenue
Gross Profit	37.4	39.4	30.8	24.4	24.4
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	48.4	60.1	75.6	50.5	43.9
Operating Profit	16.9	21.7	-8.97	2.08	6.26
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	15.4	21.4	-8.94	2.13	6.26
Provision for Income Taxes
Net Income After Taxes	11.4	16.2	-9.58	2.73	6.58
Minority Interest
Net Income Before Extraordinary Items
Net Income	11.1	15.9	-10.1	2.35	6.24
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	11.1	15.9	-10.1	2.35	6.24
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.022	0.035	0.003	0.009	0.014
Dividends per Share